Sonoma Pharmaceuticals Cash Flow Statement (2010-2013) | SNOA

Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013
Operating Activities
Net Income -2.46M-1.73M-2.19M-1.54M-2.18M-0.86M-2.61M-1.74M-0.78M-1.10M-0.95M
Share-based Compensation 0.97M368.000.33M0.53M0.81M0.52M1.01M0.46M0.40M0.37M0.27M0.20M
Gains from Investment Securities -0.00M0.16M0.06M0.12M0.13M0.14M0.15M0.15M0.16M0.16M
Cash from Operations -1.49M-1.23M-1.63M-0.07M-0.53M-0.94M-1.25M-1.31M-1.26M4.56M-1.10M-1.04M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.50M0.25M0.94M0.16M0.16M
Depreciation & Amortization (CF) 0.10M0.09M0.10M0.11M0.08M0.08M0.08M0.08M0.07M0.06M0.06M0.07M
Change in Working Capital
Change in Receivables 0.10M0.10M-0.50M-0.32M-0.05M0.21M-0.10M0.10M1.22M-0.51M0.24M-1.35M
Change in Inventory -0.01M0.10M-0.14M-0.19M0.02M0.20M0.14M-0.05M-0.09M0.02M0.02M0.15M
Change in Account Payables -0.15M0.15M-0.14M-0.13M0.12M-0.16M0.29M-0.08M-0.10M0.07M-0.28M0.29M
Change in Accured Expenses -0.03M-0.08M0.06M1.28M0.53M-0.32M-0.09M0.03M0.02M-0.09M0.35M-0.42M
Other Working Capital Changes -0.17M-0.04M0.62M-0.04M-0.11M-0.15M-0.06M0.56M0.12M4.36M-0.70M-0.55M
Investing Activities
Capital Expenditures 0.02M0.04M0.01M0.10M0.06M0.04M-0.02M0.26M0.00M0.06M0.07M0.13M
Cash from Investing Activities -0.03M-0.03M-0.01M-0.10M-0.08M-0.10M-0.05M-0.14M-0.03M-0.17M-0.05M-0.12M
Financing Activities
Other financing activities -0.03M-0.11M0.02M0.01M
Cash from Financing Activities 1.94M-0.07M0.96M-0.14M1.26M-0.31M2.63M-0.13M2.37M-0.49M-0.57M2.44M
Additional items
Exchange Rate Effect -0.01M0.02M-0.01M0.02M0.00M-0.06M0.01M-0.03M-0.02M0.02M0.00M0.02M
Change in Cash 0.41M-1.30M-0.69M-0.30M0.65M-1.40M1.34M-1.61M1.05M3.91M-1.71M1.30M
Beginning Cash Balance 6.26M6.67M5.37M4.67M4.37M5.03M3.62M4.96M3.35M4.40M8.31M-1.30M
Free Cash Flow -1.51M-1.27M-1.64M-0.17M-0.59M-0.98M-1.23M-1.57M-1.27M4.50M-1.16M-1.17M
Net Cash Flow 0.42M-1.32M-0.68M-0.32M0.65M-1.34M1.33M-1.58M1.07M3.89M-1.72M1.28M